Stocks · News reference
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001516551/000162828026061558/skye-20260908.htm
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-09-11 AccNo: 0001628280-26-061558 Size: 154 KB Item 1.02: Termination of a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events
Skye Bioscience shares rise 6% after hours on a $22M equity purchase agreement and warrant issuance.
Entry into a Material Definitive Agreement. As previously disclosed on the Current Report on Form 8-K filed by Skye Bioscience, Inc., a Nevada corporation (the "Company"), with the U.S. Securities and Exchange